WP1066 was also effective when given in vivo, where it blocked STAT3 activation (75%) in gp130757FF mouse antral tumours, and also reduced total STAT3 protein, suggesting that it may decrease expression of the Stat3 gene in the stomachs of treated mice. Here, STAT3 is linked to neoplasm.